The New Paper

November 10, 2020

Lilly receives emergency use authorization for coronavirus treatment

Eli Lilly received emergency use authorization for a coronavirus antibody treatment from the FDA yesterday. The treatment was approved for recently diagnosed, “high-risk” patients with mild to moderate symptoms. Lilly noted that it plans to produce 1M doses by the end of this year and that it will increase production “significantly” in early 2021. 

Extra: Lilly also noted that the US government has purchased 300k doses of the treatment and plans to allocate them to states proportionally based on confirmed coronavirus cases over the prior seven days.

This story is from the November 10, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.